Results 261 to 270 of about 58,432 (298)

Mechanistic Insight into Phenolic Compounds in Mitigating Diabetic Complications Induced by Advanced Glycation End Products. [PDF]

Curr Issues Mol Biol
Zaman W, Amin A.
europepmc   +1 more source

Differential impact of advanced glycation end-products on cardiovascular risk across patient populations measured by skin autofluorescence: a meta-analysis. [PDF]

Eur J Med Res
Li AC, Huang SW, Chang JT, Lin DS.
europepmc   +1 more source

Advanced Glycation End Products: A Promising Prognostic Indicator in Breast Cancer Patients. [PDF]

Breast Care (Basel)
Sahingoz Erdal G, Isiksacan N, Cikot M, Yaman M, Servi EY, Cintosun EE, Tas SK, Tasci TS, Kocamaz N, Karabulut D.   +9 more
europepmc   +1 more source

Elevated levels of advanced glycation end-products AGE10 in patients with reactive arthritis caused by Chlamydia trachomatis and Epstein-Barr virus infection. [PDF]

Immunol Res
Kril I, Zubchenko S, Havrylyuk A, Lomikovska M, Kuzan A, Jaskuła E, Chopyak V, Gamian A.   +7 more
europepmc   +1 more source

Improvement Effect and Mechanism of Hydroxytyrosol on Skin Aging Induced Advanced Glycation End Products. [PDF]

Nutrients
Fan R, Ma Y, Sun M, Zhang H, Han Y, Wang J, Zhu W, Zhang Z.   +7 more
europepmc   +1 more source

Serum advanced glycation end products (AGEs) are associated with insulin resistance

Diabetes/Metabolism Research and Reviews, 2011
Background: In addition to the important role of advanced glycation end products (AGEs) in the pathogenesis of diabetic vascular complications, recent data suggest that advanced glycation end products can also impair insulin action in vitro.
Kathryn C B Tan, Ying Wong
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics

Analytical Biochemistry, 2004
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown.
Valencia, J.V., Weldon, S.C., Quinn, D., Kiers, G.H., Groot, J. de, TeKoppele, J.M., Hughes, T.E.   +6 more
openaire   +3 more sources

Advanced Glycation End Products

2011
Prolonged hyperglycemia, dyslipidemia and oxidative stress in diabetes result in the increased production and accumulation of advanced glycation end products (AGEs) in the kidney. Covalent AGE modifications significantly influence the structure and function of key protein targets.
openaire   +2 more sources

Advanced glycation end products and diabetic retinopathy

Amino Acids, 2011
Retinopathy is a serious microvascular complication of diabetes and a major cause of blindness in young adults, worldwide. Early diabetic retinopathy is characterized by a loss of pericytes from retinal capillaries, the appearance of acellular capillaries and microaneurysms, and a breakdown of the blood-retinal barrier. In later stages, this can evolve
Ross, Milne, Seymour, Brownstein
openaire   +2 more sources